Literature DB >> 9973579

Frequency of apolipoprotein E (APOE) allele types in patients with Chlamydia-associated arthritis and other arthritides.

H C Gérard1, G F Wang, B J Balin, H R Schumacher, A P Hudson.   

Abstract

Genetic background is important in determining whether certain infecting bacteria disseminate to the joint and cause arthritis. We assessed whether APOE genotype is associated with the presence of DNA from Chlamydia or other bacteria in synovial tissues of patients with various arthritides. Nucleic acids from synovial tissues of 135 patients were screened by PCR for DNA from Chlamydia trachomatis, C. pneumoniae and other bacteria (pan-bacteria). APOE genotype was determined by a PCR-based method for all patients in each of four resulting groups comprised of about 35 individuals each, positive for C. trachomatis only, C. pneumoniae only, other bacteria, or no bacteria. RT-PCR was used to assess synovial APOE expression. The latter assays confirmed that APOE mRNA is present in synovial tissue. Determination of APOE genotype showed that patients PCR-negative in all assays, and those positive in the C. trachomatis - and pan-bacteria- (excluding Chlamydia) directed assays, had distributions of the APOE epsilon2, epsilon3 and epsilon4 alleles mirroring those of the general population (i.e. about 8%, 79% and 13%, respectively). In contrast, 68% of patients with C. pneumoniae DNA in synovium possessed a copy of the epsilon4 allele. These results indicate that no association exists between APOE genotype and synovial presence of C. trachomatis or other bacteria. However, individuals bearing at least one copy of the APOE epsilon4 allele may be at increased risk for synovial infection by C. pneumoniae. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973579     DOI: 10.1006/mpat.1998.0242

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  8 in total

1.  Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders.

Authors:  Carlo Contini; Silva Seraceni; Rosario Cultrera; Massimiliano Castellazzi; Enrico Granieri; Enrico Fainardi
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-21

2.  Chlamydia pneumoniae Infection and Inflammatory Diseases.

Authors:  Rebecca A Porritt; Timothy R Crother
Journal:  For Immunopathol Dis Therap       Date:  2016

Review 3.  Causality of Chlamydiae in Arthritis and Spondyloarthritis: a Plea for Increased Translational Research.

Authors:  Henning Zeidler; Alan P Hudson
Journal:  Curr Rheumatol Rep       Date:  2016-02       Impact factor: 4.592

Review 4.  Emerging Roles of Apolipoprotein E and Apolipoprotein A-I in the Pathogenesis and Treatment of Lung Disease.

Authors:  Xianglan Yao; Elizabeth M Gordon; Debbie M Figueroa; Amisha V Barochia; Stewart J Levine
Journal:  Am J Respir Cell Mol Biol       Date:  2016-08       Impact factor: 6.914

5.  Herpes Infections and Dementia: Rebutting Alternative Fact.

Authors:  Richard Lathe; Nian-Sheng Tzeng; Ruth Itzhaki
Journal:  Neurotherapeutics       Date:  2019-01       Impact factor: 7.620

6.  THE EXPOSOME IN HUMAN EVOLUTION: FROM DUST TO DIESEL.

Authors:  Benjamin C Trumble; Caleb E Finch
Journal:  Q Rev Biol       Date:  2019-12       Impact factor: 6.750

Review 7.  Chlamydia pneumoniae: An Etiologic Agent for Late-Onset Dementia.

Authors:  Brian J Balin; Christine J Hammond; Christopher Scott Little; Susan T Hingley; Zein Al-Atrache; Denah M Appelt; Judith A Whittum-Hudson; Alan P Hudson
Journal:  Front Aging Neurosci       Date:  2018-10-09       Impact factor: 5.750

Review 8.  Evolution of virulence.

Authors:  Paul W Ewald
Journal:  Infect Dis Clin North Am       Date:  2004-03       Impact factor: 5.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.